Among the people who reported symptoms, 11 were hospitalized, the CDC said, but none have died.The patients, ages 25 to 59, reported their symptoms between November and March, and most of them ...

Shares of Swiss drugmaker Novartis rallied after the company’s first-quarter sales surpassed analysts’ expectations, and it raised its full-year guidance. Novartis executives touted strong ...

This outlines the approach that should be taken when there is no NICE guidance. NICE will review the position if the company decides that it wants to make an evidence submission.

Update: On the conference call, Texas Instruments management said revenue was down across all markets, with industrial down upper single digits and communications equipment down 25%. Gross margins ...

People being held at P.E.I.'s provincial jail will now be able to make phone calls to anyone they want, as long as they are not blocked by court orders, after an intervention by the Island's ...

(RTTNews) - Danaher Corporation (DHR) said, for the second quarter, the company anticipates that non-GAAP core revenue will be down mid-single digits year-over-year. For full year 2024, the ...

CDC director Mandy Cohen said Monday in a news briefing. “Heat can impact our health, but heat-related illness and death are preventable,” Cohen said. Heat kills more people in the U.S. each ...

Louisiana state superintendent of education pens letter to President Biden with concerns over Title IX guidance Short and Impactful: The Top 24 Actors Who Defied Height Stereotypes 3 reasons you ...

People being held at P.E.I.'s provincial jail will now be able to make phone calls to anyone they want, as long as they are not blocked by court orders, after an intervention by the Island's ...

As the US prepares for another summer of potentially record-breaking heat, the Biden administration on Monday unveiled a new tool to help Americans anticipate high temperatures and their potential ...

Wipro has beaten the Street estimates with a 5 percent rise in net profit for the January-March quarter, but persisting cost-cutting measures, decline in headcount and a sluggish guidance for the ...

For information, the company have announced that phase 2 HIMALAYA study did not meet its primary endpoint in ALSFRS-R and therefore they will no longer be pursuing a Marketing Authorisation ...